Cargando…

Real-world evidence in antiretroviral therapy: drug safety data

Detalles Bibliográficos
Autores principales:	Silva, Ana-Marta, Pereira, Marta, Dias, Cláudia Camila, Ventura, Ângela, Sousa-Pinto, Bernardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392085/ https://www.ncbi.nlm.nih.gov/pubmed/32417161 http://dx.doi.org/10.1016/j.bjid.2020.04.013

Ejemplares similares

Real-world Evidence of the Herb-drug Interactions
por: Pan, Hsueh-Yi, et al.
Publicado: (2022)

Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence
por: Marchetti, Monia, et al.
Publicado: (2022)

Safety of ustekinumab in adolescent patients with moderate‐to‐severe plaque psoriasis: real‐world evidence from an ongoing European study (NCT03218488)
por: Mahé, E., et al.
Publicado: (2022)

An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence
por: Xiao, Cao, et al.
Publicado: (2018)

Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review
por: Lasky, Tamar, et al.
Publicado: (2020)

Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps
por: Sousa-Pinto, Bernardo, et al.
Publicado: (2023)

MASK‐air(®) real‐world data in respiratory allergy in old‐age adults
por: Taborda‐Barata, Luis, et al.
Publicado: (2023)

Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations
por: Horton, Daniel B., et al.
Publicado: (2021)

Real‐world evidence for preventive effects of statins on cancer incidence: A trans‐Atlantic analysis
por: Gohlke, Bjoern‐O, et al.
Publicado: (2022)

Tiotropium safety in ‘real‐world’ populations: Response to Schmiedl, et al. in the British Journal of Clinical Pharmacology
por: Wise, Robert, et al.
Publicado: (2016)

Evidence-based TDM for antiretroviral drugs
por: Solas, Caroline
Publicado: (2010)

Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy
por: Gomes, Ana Rita, et al.
Publicado: (2016)

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
por: Chan, Kelvin, et al.
Publicado: (2020)

Drug-Coated Balloons for Unselected Real World Patients: Are We There Yet?
por: Alfonso, Fernando, et al.
Publicado: (2022)

Challenges in Procalcitonin Implementation in the Real-World
por: Nguyen, Cynthia T, et al.
Publicado: (2018)

Real-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario
por: Jain, Prashant, et al.
Publicado: (2017)

Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence
por: Romano, Alicia, et al.
Publicado: (2021)

Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence
por: Parikh, Raunak, et al.
Publicado: (2023)

Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia
por: Mody, Aaloke, et al.
Publicado: (2018)

Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021)

Editorial: Real-World evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2022)

Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2023)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Effectiveness and Safety of Sacubitril/Valsartan in Patients with Chronic Kidney Disease—A Real-World Experience
por: Pereira, Sara C., et al.
Publicado: (2023)

Biologics in severe asthma: the role of real-world evidence from registries
por: Paoletti, Giovanni, et al.
Publicado: (2022)

Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience
por: Levra, Stefano, et al.
Publicado: (2022)

Hypersensitivity to antiretroviral drugs a case report
por: Sousa, Maria, et al.
Publicado: (2014)

1555 Factors Associated with the Selection of Initial Antiretroviral Therapy: Real-world Channeling
por: Saag, Michael, et al.
Publicado: (2014)

Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis
por: Teixeira, Ana, et al.
Publicado: (2021)

“Drugs are a taboo”: a qualitative and retrospective study on the role of education and harm reduction strategies associated with the use of psychoactive substances under the age of 18
por: da Silva, Gabriela Almeida Pinto, et al.
Publicado: (2021)

Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence
por: Kumar, Viveka, et al.
Publicado: (2018)

Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real‐world evidence in Japan
por: Fujita, Hideki, et al.
Publicado: (2020)

Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
por: Moser, Tobias, et al.
Publicado: (2022)

Safety data in randomised real-world evidence studies: Salford Lung Study learnings
por: Harvey, Catherine, et al.
Publicado: (2021)

Informing real-world practice with real-world evidence: the value of PRECIS-2
por: Neta, Gila, et al.
Publicado: (2018)

Proceed with Caution When Using Real World Data and Real World Evidence
por: Kim, Hun-Sung, et al.
Publicado: (2019)

4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies
por: Pham, Jessica, et al.
Publicado: (2020)

Drugs: Real World Outcomes
por: Peters, Dene C., et al.
Publicado: (2014)

Bisphosphonate Drug Holidays: Evidence From Clinical Trials and Real‐World Studies
por: Wang, Mawson, et al.
Publicado: (2022)

The Missing Reality of Real Life in Real‐World Evidence
por: Okun, Sally
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ckuj5p2m3452fffoafkptns9j5